Cargando…
Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays
The heterogeneity and poor prognosis associated with gliomas, makes biomarker identification imperative. Here, we report autoantibody signatures across various grades of glioma serum samples and sub-categories of glioblastoma multiforme using Human Proteome chips containing ~17000 full-length human...
Autores principales: | Syed, Parvez, Gupta, Shabarni, Choudhary, Saket, Pandala, Narendra Goud, Atak, Apurva, Richharia, Annie, KP, Manubhai, Zhu, Heng, Epari, Sridhar, Noronha, Santosh B., Moiyadi, Aliasgar, Srivastava, Sanjeeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570193/ https://www.ncbi.nlm.nih.gov/pubmed/26370624 http://dx.doi.org/10.1038/srep13895 |
Ejemplares similares
-
Evaluation of autoantibody signatures in meningioma patients using human proteome arrays
por: Gupta, Shabarni, et al.
Publicado: (2017) -
A Protein Microarray-Based Investigation of Cerebrospinal Fluid Reveals Distinct Autoantibody Signature in Low and High-Grade Gliomas
por: Gahoi, Nikita, et al.
Publicado: (2020) -
Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors
por: Ghantasala, Saicharan, et al.
Publicado: (2021) -
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
por: Sharma, Samridhi, et al.
Publicado: (2014) -
Subventricular zone involvement in Glioblastoma – A proteomic evaluation and clinicoradiological correlation
por: Gollapalli, Kishore, et al.
Publicado: (2017)